Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administration to launch a generic form of blood pressure tablet Opsumit.Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administr
A blockbuster cancer drug in the US with annual sales of over $8 billion may just become a win-win for all stakeholders - the innovator, domestic generic companies as well as patients. This is in the wake of a 'unique' patent settlement where US majo
The times are changing, so are the methods in which the pharmaceutical sector used to function.
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers on Friday released guidelines for 'Strengthening of Pharmaceutical Industry (SPI)' scheme that is seen to address rising demand in terms of support required to existing Pharma clust
Taking positive cues from Nifty healthcare index, domestic pharma stocks outperformed all other sectoral stocks on Friday, with shares of Cipla leading the pack.
Indian vaccine maker Bharat Biotech said on Friday the Russia-Ukraine conflict had not impacted the company's supply chains so far. Unlike several Western companies including McDonald's, Microsoft, Coca-Cola and Starbucks that have stopped sales or
As the healthcare industry across the globe has started focusing increasingly on outcomes, pharma companies are looking to sources beyond Randomized Clinical Trials (RCTs) to measure and demonstrate the value they bring.
Pharmaceutical major Dr. Reddy's Laboratories Ltd said it is focused on employee safety and business continuity in and around Russia, despite many Western companies pulling out from Russia in recent days. No Indian company has publicly withdrawn from
Indian pharmaceutical major Dr. Reddy's Laboratories Ltd said it is focused on business continuity in and around Russia, as Indian drug exporters’ brace for temporary disruptions to sales due to the Ukraine crisis. No Indian company has publicly wit.
Christian Medical College (CMC) Vellore will soon share preliminary results of a study to test the feasibility of mixing Covishield and Covaxin - the two main Covid-19 vaccines available in the country - with the country's drug regulator, a senior of
, CDSCO.jpg)
